ACAD Financial Facts
Loss from operations: -6.16MTotal operating expenses: 6.58M
See Full Income Statement
Prepaid expenses, receivables and other current assets: 1.52M
Accumulated deficit: -373.84M
See Full Balance Sheet
Earnings History for ACADIA Pharmaceuticals (ACAD)
|
Expand Research on ACAD
| Next EPS Date | 8/7/13 *Est. | EPS Growth Rate | +33.3% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +12.5% | Revenue Growth Rate | -7.3% *Last Qtr. |
| Average % Move 1-Wk after EPS | +4.2% |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Estimize EPS/Revs | Gd. | % Since | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5/7/13 | Q113 | -$0.08 | -$0.08 | $0.00 | $417K | $450K | N/A / N/A | N/A | +11.9% | Details | |
| 3/12/13 | Q412 | -$0.11 | -$0.09 | -$0.02 | $380K | $470K | N/A / N/A | N/A | +109.3% | Details | |
11/5/12  |
 |
Q312 | -$0.04 | -$0.09 | +$0.05 | $3.5M | $1.9M | N/A / N/A | N/A | +484.6% | Details |
| 8/8/12 | Q212 | -$0.10 | -$0.12 | +$0.02 | $599K | $490K | N/A / N/A | N/A | +778.8% | Details | |
| 5/8/12 |
|
Q112 | -$0.12 | -$0.11 | -$0.01 | $450K | $500K | N/A / N/A | N/A | +761.7% | Details |
| 3/6/12 |
|
Q411 | -$0.10 | -$0.10 | $0.00 | $588K | $550K | N/A / N/A | N/A | +815.2% | Details |
| 11/9/11 |
|
Q311 | -$0.10 | -$0.10 | $0.00 | $584K | $500K | N/A / N/A | N/A | +1005.8% | Details |
| 8/10/11 | Q211 | -$0.12 | -$0.15 | +$0.03 | $460K | $480K | N/A / N/A | N/A | +847.9% | Details |
